A Small-scale Phase IV Clinical Trial of Two Non-ergot Dopamine Agonists: Slowly Switching from Ropinirole to Pramipexole in Patients with Parkinson''s Disease
碩士 === 臺北醫學大學 === 藥學研究所 === 97 === Background: Dopamine receptor agonists (DAs), especially D2 subtype could be used as monotherapy in patients with early Parkinson’s disease (PD) or adjunctive therapy to L-DOPA in advanced PD with motor complications. DAs are divided into ergot and non-ergot agent...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2009
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/59967084075455423785 |